Community actions
-
Holding
-
Recently bought
-
Recently sold
Sarepta Therapeutics, Inc. news
-
Sarepta recent weakness brings buying opportunity, says JPMorgan
-
SRPT Beats on Q3 Earnings & Sales, Discontinues PPMO-Based DMD Program
-
Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript
-
Sarepta Therapeutics Inc (SRPT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
-
Sarepta Therapeutics (SRPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sarepta Therapeutics, Inc. (SRPT): An Unstoppable Stock That Could Make You Richer
-
Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results
Recent Motivations
-
Elin Rothzén
Bought4 shares of
-
📈 Grafen ser bra ut 💡 Litar på magkänslan
-
-
Martin Blomqvist
Bought5 shares of-
💡 Litar på magkänslan 📈 Grafen ser bra ut
-
-
Кирилл Золотарев
Sold18 shares of-
📊 I think it's overvalued right now
-
-
Кирилл ЗолотаревBought11 shares of
-
Кирилл ЗолотаревBought1 shares of
-
📈 The chart looks bullish
-